Company Filing History:
3 out of 1,745 
2 out of 132 
2 out of 321 
Years Active: 2017-2019
Title: Bernhard Mlecnik: Innovator in Cancer Research
Introduction
Bernhard Mlecnik is a prominent inventor based in Paris, France. He has made significant contributions to the field of cancer research, particularly in the quantification of immune cells in tumoral tissues. His innovative methods have the potential to improve patient prognoses and treatment strategies.
Latest Patents
Mlecnik holds 3 patents, with his latest inventions focusing on critical advancements in cancer diagnostics. One of his notable patents is a method for quantifying immune cells in tumoral tissues. This method involves several steps, including providing immunostained tissue slices, digitalizing these slides, and analyzing the tissue sections to assess the number and density of immune cells. Another significant patent relates to predicting the survival time of patients suffering from solid cancers based on the density of B cells at the invasive margin of tumors. This method allows for better prognostic assessments by comparing B cell densities with predetermined reference values.
Career Highlights
Throughout his career, Mlecnik has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université Paris Descartes. His work has been instrumental in advancing the understanding of immune responses in cancer.
Collaborations
Mlecnik has collaborated with notable colleagues, including Jerome Galon and Franck Pages. These partnerships have further enriched his research and contributed to the development of innovative cancer treatment methodologies.
Conclusion
Bernhard Mlecnik's contributions to cancer research through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in cancer diagnostics and patient care.